Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
Sun Pharma emerged as the star performer and closed 4.03 per cent up at Rs 675.45, while Cipla rallied 1.58 per cent to Rs 592.60.
Indian auto and pharma industries import several critical components and raw materials from China.
They seek to profit from big-selling drugs going off-patent this year in the lucrative market.
Gains in banking ICICI Bank, Tata Motors and Wipro was offest by losses in ITC, HDFC and Sun Pharma.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
'Even if Serum Institute and Bharat Biotech were successful in ramping up production overnight, what happens to the capacity after the demand from India is met?' asks Sanjeev Nayyar.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
Face NPPA fine for overcharging on anti-asthma drug
Entering Iran may lead to trouble for those having significant presence in the US market.
While several export-oriented Indian companies such as Cipla and Reliance Industries Ltd (RIL) are rejoicing at the prospects of the rupee falling further, others that are importing raw materials such as coal and oil might see a big hole in their bottom line.
Companies run till now by mostly their promoters are increasingly inducting professionals to head their teams.
Reliance Industries rose by 1.16 per cent while ITC and ICICI Bank zoomed up to 2 per cent, lifting the indices to all time high levels.
Ajit Mishra, vice president, Research, Religare Broking, answers readers' queries on stocks they own or want to buy.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
Yusuf Hamied, Anji Reddy and Parvinder Singh are the real pioneers of the Indian pharmaceutical industry.
The health ministry on Saturday recommended the use of antiviral drug remdesivir in moderate stage of COVID-19 while backtracking from its earlier stance on hydroxychloroquine, saying the anti-malarial drug should be used in the early course of the disease and not on critically ill patients.
Regulator says fee would enable it to quicken approval process.
A probe finds several pharma majors in breach of the law; and in turn they blame the government.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
Ajit Mishra, Vice President, Research, Religare Broking, answers readers' queries on a weekly basis.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
The broader Nifty closed higher by 7.30 points
To some -- especially western drug companies -- he is a 'pirate'. To others, mostly those in developing countries, he is an unparalleled hero. Either way, Yusuf Hamied, 75, is perhaps the most talked about man in pharmaceutical circles in the last decade.
This move could cost $299 million a year for Indian pharma players.
Snapping a four-day gaining streak, the BSE benchmark Sensex on Thursday fell over 57 points in early trade due to profit-booking after recent gains amid a mixed trend in other Asian markets.
The western world had largely considered India to be a production hub, and also, a good potential geography for clinical trials, and a big market. But in Covid-19 research, Indian companies and government researchers are also researching new drug candidates and potential vaccines, says Prosenjit Datta.
The Sensex rallied to a high of 18,973 in mid-week trade, rising about 220 points from the previous week's close.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries
The antiviral drug may cost around Rs 55,000 for an 11-dose course, or Rs 5,000 per injection -- much less than the price of imports from Bangladesh, reports Sohini Das.
Sun Pharma stock has appreciated at 35% a year for 20 years
European countries are trying to woo back the Indian customers they had lost following seizure of drug consignments by Customs authorities of several European Union members.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
The National Pharmaceutical Pricing Authority, which regulates the prices of medicines, has identified around 70 anti-cancer drugs, including anti-breast cancer medication Letrozole and anti-blood cancer drug Imatinib, for detailed price analysis.
ITC, Sun Pharma, Cipla and Tata Steel were top gainers on BSE Sensex
Aggressive smaller players are serving a bitter pill to the big boys in the pharmaceutical sector.
Over 550,000 small drug retailers in the country are transforming into producers and marketers of pharmaceutical products, readying to compete with companies such as Ranbaxy, Cipla, Sun Pharma and Lupin whose produce they sell.
The rupee's appreciation of 6.4 per cent against the dollar and 12 per cent against the euro is likely to hurt the first-quarter performance of the pharmaceutical sector, indicate a results' preview by broking houses.
As many as 14 Indian families have made it to the inaugural list of Forbes' 50 richest families in Asia.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances